| Issue |
Section |
Title |
File |
| Vol 78, No 5 (2003) |
Editorial |
Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up |
|
| Vol 79, No 12 (2004) |
Editorial |
Antibodies to cyclic citrullinized peptide in rheumatoid arthritis |
|
| Vol 80, No 5 (2008) |
Editorial |
Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL) |
|
| Vol 80, No 5 (2008) |
Editorial |
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection |
|
| Vol 80, No 5 (2008) |
Editorial |
Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis |
|
| Vol 81, No 6 (2009) |
Editorial |
Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions |
|
| Vol 81, No 6 (2009) |
Editorial |
Cardiovascular risk in psoriatic arthritis |
|
| Vol 81, No 6 (2009) |
Editorial |
Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis |
|
| Vol 84, No 5 (2012) |
Editorial |
THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME |
|
| Vol 84, No 12 (2012) |
Editorial |
Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: Preliminary data |
|
| Vol 85, No 3 (2013) |
Editorial |
Change in the blood cytokine spectrum in patients with pulmonary sarcoidosis |
|
| Vol 85, No 1 (2013) |
Editorial |
Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome |
|
| Vol 85, No 5 (2013) |
Editorial |
The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis |
|
| Vol 85, No 5 (2013) |
Editorial |
Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis |
|
| Vol 85, No 5 (2013) |
Editorial |
Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: A pilot study |
|
| Vol 85, No 5 (2013) |
Editorial |
Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab |
|
| Vol 86, No 5 (2014) |
Editorial |
Systemic autoimmune rheumatic diseases in 2013: Problems of laboratory diagnosis |
|
| Vol 86, No 5 (2014) |
Editorial |
Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment |
|
| Vol 86, No 5 (2014) |
Editorial |
Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses |
|
| Vol 87, No 5 (2015) |
Editorial |
Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy |
|
| Vol 87, No 8 (2015) |
Editorial |
IgG4-related salivary gland lesions |
|
| Vol 88, No 5 (2016) |
Editorial |
Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis |
(Rus)
|
| Vol 88, No 5 (2016) |
Editorial |
N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs |
(Rus)
|
| Vol 89, No 5 (2017) |
Editorial |
The influence of STAT4 rs7574865 (G/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study |
(Rus)
|
